Oops! It appears that you have disabled your Javascript. In order for you to see this page as it is meant to appear, we ask that you please re-enable your Javascript!

News

News

DuPont Chosen to Provide Probiotics for International Pediatric Sepsis Research

WILMINGTON, Del., April 25, 2019 – It is estimated that nearly 3 million newborns and 1.2 million children suffer from sepsis globally each year1, with limited effective forms of prevention currently available. To help combat this, DuPont Nutrition & Biosciences (DuPont), the global leader in probiotics, will provide clinical trial probiotic and prebiotic products to the Centre for Global Child Health at The Hospital for Sick Children (SickKids) in Toronto for its research on the effects of probiotics on sepsis in infants.

DuPont Achieves Major Milestone to Expand Probiotics Capacity

ROCHESTER, NY, March 28, 2019 – DuPont today announced it has completed construction on a new, state-of-the art probiotics fermentation unit at its Rochester, New York, facility. The unit, now largest in the world, is part of a multiphase nearly $100 million investment to expand probiotics capacity and enhance the company’s leadership in delivering high-quality, clinically documented probiotics to dietary supplement and food and beverage manufacturers.

DuPont Nutrition & Health and Lonza Specialty Ingredients Announce Joint Agreement in Human Milk Oligosaccharides

COPENHAGEN, Denmark, Feb. 27, 2019 – DuPont Nutrition & Health and Lonza Specialty Ingredients announce an agreement under which the leading biotechnology and specialty ingredient company Lonza will manufacture and supply CARE4U™ 2’-FL – a human milk oligosaccharide (HMOs). This strategic manufacturing collaboration reinforces market confidence in the supply and premium quality of this specialty ingredient.

DuPont Nutrition & Health Commits to Driving “Healthy China 2030” with Probiotics

KUNSHAN, CHINA, December 13, 2018 – Today, DuPont Nutrition & Health presented on the latest developments on clinical research, market insights and trends on global probiotics products at the 3rd Probiotics and Health Medical Science Summit. Top food safety and clinical experts in China exchanged the standards and safety of probiotics and domestic clinical research results with focus on digestion, immunity, women’s & children’s health, and internal microbiota regulation. The summit attracted close to 50 chief physicians from the Department of Gastroenterology, Nutrition, Dermatology, Endocrinology and Internal Medicine of leading Third-Level Grade-A hospitals across the country.

DuPont Nutrition & Health Helps to Reduce Health Risks for Overweight Consumers

WILMINGTON, Del., Dec. 11, 2018 – DuPont Nutrition & Health has released new findings from a clinical study of a synbiotic dietary supplement that gives hope to overweight consumers at risk of health complications. Combining the benefits of a proven probiotic with a prebiotic fiber, HOWARU® Shape has proven potential to improve metabolic health while supporting weight loss.